Digoxin Immune Fab

Digitoxin is a cardiac glycoside (CG). It is a cardiotonic drug, which exhibits cardiac and anti-cancer properties. Digitoxin inhibits nuclear factor kappa B (NF-κB) signaling. It is used to treat congestive heart failure and cardiac arrhythmia.

Digitoxin is a cardiac glycoside (CG). It is a cardiotonic drug, which exhibits cardiac and anti-cancer properties.

Digitoxin is a cardiac glycoside (CG). It is a cardiotonic drug, which exhibits cardiac and anti-cancer properties.

Digitoxin is a cardiac glycoside (CG). It is a cardiotonic drug, which exhibits cardiac and anti-cancer properties.

Digitoxin is a cardiac glycoside (CG). It is a cardiotonic drug, which exhibits cardiac and anti-cancer properties.

Digitoxin is a cardiac glycoside (CG). It is a cardiotonic drug, which exhibits cardiac and anti-cancer properties.

Digoxigenin is a therapeutic drug belonging to the group of cardiac glycosides, widely used in the management of congestive heart failure and other cardiac diseases. Application Digoxigenin is used as an analytical reference standard for the

Digoxigenin is a therapeutic drug belonging to the group of cardiac glycosides, widely used in the management of congestive heart failure and other cardiac diseases. Application Digoxigenin is used as an analytical reference standard for the

Digoxigenin is a therapeutic drug belonging to the group of cardiac glycosides, widely used in the management of congestive heart failure and other cardiac diseases. Application Digoxigenin is used as an analytical reference standard for the

CAS No.: 1672-46-4

Formula: C41H64O14 Formula weight: 780.95 Purity: 96% CAS Number: 20830-75-5 UN Number: UN2811 Hazard Class: 6.

Formula: C41H64O14 Formula weight: 780.95 Purity: 96% CAS Number: 20830-75-5 UN Number: UN2811 Hazard Class: 6.